When an opioid imbalance was introduced after cholestasis, an increased opioidergic tone resulted in cholestatic itch, likely through the decreased peripheral or central activation of mu-opioid receptors and the balance shifting towards favoring kappa opioid receptor activation [31,32]. The gene discussed is OPRM1; the disease is cholestasis.